TNPSC Thervupettagam

ChAdOx1 COVID-19 vaccine

July 23 , 2020 1590 days 848 0
  • It was jointly developed by British-Swedish company AstraZeneca and the University of Oxford.
  • It has been found to be safe and induced an immune response in early-stage clinical trial.
  • Serum institute of India, the partner in the development of Oxford Vaccine, is planning to start the clinical trials in India.
  • The company is the world's largest vaccine producer by number of doses produced.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories